Last updated on August 2013

Studying Blood Samples in Young Patients With Cytopenia After a Donor Stem Cell Transplant


Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: Leukemia | Myelodysplastic Syndromes
  • Age: - 17 Years
  • Gender: Male or Female
  • Other:
    DISEASE CHARACTERISTICS:
    Diagnosed with refractory cytopenia
    Hypocellular bone marrow and normal karyotype
    Underwent stem cell transplantation (SCT) from an HLA identical (8/8) sibling, an HLA
    identical (10/10) relative, or an HLA identical or single allelic disparate unrelated
    donor
    Received a preparative regimen including either thiotepa or fludarabine
    phosphate
    Concurrently enrolled on EWOG-MDS-2006
    PATIENT CHARACTERISTICS:
    Not specified
    PRIOR CONCURRENT THERAPY:
    See Disease Characteristics

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.